These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 23488062)
1. The profit of prestigious cancer care. Time; 2013 Mar; 181(8):50-5. PubMed ID: 23488062 [No Abstract] [Full Text] [Related]
2. How the sequester cuts are harming oncology. Eagle D; Diaz M Oncology (Williston Park); 2013 May; 27(5):364, 366. PubMed ID: 25184256 [No Abstract] [Full Text] [Related]
3. New Medicare bill targets discrepancies in fees for cancer drugs, outpatient services. Twombly R J Natl Cancer Inst; 2004 Feb; 96(3):166-8. PubMed ID: 14759976 [No Abstract] [Full Text] [Related]
6. Cashing in on royalties. Sloan-Kettering reaps 142 million dollars in deal. Becker C Mod Healthc; 2005 Aug; 35(35):18-9. PubMed ID: 16161906 [No Abstract] [Full Text] [Related]
7. Cost of new oncology drugs. Newcomer L Clin Adv Hematol Oncol; 2010 May; 8(5):313-4. PubMed ID: 20551889 [No Abstract] [Full Text] [Related]
8. Reimbursement for chemotherapy drugs used in office practice. Bailes JS Oncology (Williston Park); 1991 Oct; 5(10):27. PubMed ID: 1838268 [No Abstract] [Full Text] [Related]
9. Oral/infusion cancer drug parity begins to raise health plan costs. Carroll J Manag Care; 2012 Jan; 21(1):7-8. PubMed ID: 22334937 [No Abstract] [Full Text] [Related]
10. 2005 Medicare payments for chemotherapy will exceed costs. Zielinski SL J Natl Cancer Inst; 2005 Jan; 97(1):7. PubMed ID: 15632370 [No Abstract] [Full Text] [Related]
12. Paying a high price for cancer drugs. Lancet; 2015 Aug; 386(9992):404. PubMed ID: 26251376 [No Abstract] [Full Text] [Related]
13. Frustration over gray-market drugs lingers throughout nation. Rosenthal ET J Natl Cancer Inst; 2012 Feb; 104(4):264-7. PubMed ID: 22327382 [No Abstract] [Full Text] [Related]
14. Few patients worry about cost of supportive care drugs. J Support Oncol; 2009; 7(4):150. PubMed ID: 19731585 [No Abstract] [Full Text] [Related]
15. At the center of cancer care. For-profit outpatient centers playing bigger role in treatment, clinical trials. Saphir A Mod Healthc; 1999 May; 29(22):28-30. PubMed ID: 10537911 [TBL] [Abstract][Full Text] [Related]
16. Editorial. 'An English compromise'. Eur J Cancer Care (Engl); 2009 Jan; 18(1):1-2. PubMed ID: 19473219 [No Abstract] [Full Text] [Related]
17. Should NHS patients be allowed to pay extra for their care? Pragmatism should rule, not policy committees. Osborne R BMJ; 2002 Jan; 324(7329):110. PubMed ID: 11808519 [No Abstract] [Full Text] [Related]
18. Cancer centers brace for payment cuts. Lutz S Mod Healthc; 1988 Mar; 18(11):75, 77. PubMed ID: 10302229 [No Abstract] [Full Text] [Related]
19. The cancer pill not taken costs insurers in long run. Diamond F Manag Care; 2012 Dec; 21(12):20-3, 28. PubMed ID: 23301347 [No Abstract] [Full Text] [Related]
20. The impact of reimbursement on quality cancer care. Mortenson LE Bus Health; 1988 May; 5(7):38-40. PubMed ID: 10287398 [No Abstract] [Full Text] [Related] [Next] [New Search]